Yahoo Web Search

Search results

    • Q1 2024 Acumen Pharmaceuticals Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 3 hours ago

      But anyway, for the subcu, I don't think we look at that as being different than we saw in our INTERCEPT study in terms of plaque reduction versus oligomer target engagement